Stock listing

KRX:475830 Orum Therapeutics, Inc. (오름테라퓨틱) 주가

Follow Orum Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · KRX:475830

₩17,710 KRW +690 (+4.1%)

Close on Oct 14, 2026

Orum Therapeutics, Inc. logo
Ticker
KRX:475830
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate

Aug 23, 2026

Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors

Apr 13, 2026

Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026

Mar 17, 2026

Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153 at the 2025 American Society of Hematology (ASH) Annual Meeting

Nov 3, 2025

Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications

Oct 14, 2025

All Orum Therapeutics, Inc. news

Decks

Orum Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
4 in the last 12 months · 5 in all · newest Aug 23, 2026 · oldest 2025
Decks
1 deck · latest 2026

Log in to ask 6ix AI your own questions about Orum Therapeutics, Inc.